Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.17 CAD -8.11% Market Closed
Market Cap: 6.9m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Intrinsic Value

IOT doesn't have a meaningful market cap.

The intrinsic value of one IOT stock under the Base Case scenario is 0.07 CAD. Compared to the current market price of 0.17 CAD, Innovotech Inc is Overvalued by 60%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IOT Intrinsic Value
0.07 CAD
Overvaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Innovotech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IOT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IOT?
Bearish
Neutral
Bullish

Fundamental Analysis

Innovotech Inc
CA
Life Sciences Tools & Services
Market Cap
6.6m CAD
IPO
May 28, 2003
Employees
-
Canada
Market Cap
6.6m CAD
Industry
Life Sciences Tools & Services
IPO
May 28, 2003

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Innovotech Inc

Provide an overview of the primary business activities
of Innovotech Inc.

What unique competitive advantages
does Innovotech Inc hold over its rivals?

What risks and challenges
does Innovotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Innovotech Inc.

Provide P/S
for Innovotech Inc.

Provide P/E
for Innovotech Inc.

Provide P/OCF
for Innovotech Inc.

Provide P/FCFE
for Innovotech Inc.

Provide P/B
for Innovotech Inc.

Provide EV/S
for Innovotech Inc.

Provide EV/GP
for Innovotech Inc.

Provide EV/EBITDA
for Innovotech Inc.

Provide EV/EBIT
for Innovotech Inc.

Provide EV/OCF
for Innovotech Inc.

Provide EV/FCFF
for Innovotech Inc.

Provide EV/IC
for Innovotech Inc.

Compare the intrinsic valuations
of Innovotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Innovotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Innovotech Inc compared to its peers.

Compare the P/E ratios
of Innovotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Innovotech Inc with its peers.

Analyze the financial leverage
of Innovotech Inc compared to its main competitors.

Show all profitability ratios
for Innovotech Inc.

Provide ROE
for Innovotech Inc.

Provide ROA
for Innovotech Inc.

Provide ROIC
for Innovotech Inc.

Provide ROCE
for Innovotech Inc.

Provide Gross Margin
for Innovotech Inc.

Provide Operating Margin
for Innovotech Inc.

Provide Net Margin
for Innovotech Inc.

Provide FCF Margin
for Innovotech Inc.

Show all solvency ratios
for Innovotech Inc.

Provide D/E Ratio
for Innovotech Inc.

Provide D/A Ratio
for Innovotech Inc.

Provide Interest Coverage Ratio
for Innovotech Inc.

Provide Altman Z-Score Ratio
for Innovotech Inc.

Provide Quick Ratio
for Innovotech Inc.

Provide Current Ratio
for Innovotech Inc.

Provide Cash Ratio
for Innovotech Inc.

What is the historical Revenue growth
over the last 5 years for Innovotech Inc?

What is the historical Net Income growth
over the last 5 years for Innovotech Inc?

What is the current Free Cash Flow
of Innovotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Innovotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innovotech Inc

Current Assets 449.9k
Cash & Short-Term Investments 120.5k
Receivables 204.8k
Other Current Assets 124.6k
Non-Current Assets 660.8k
PP&E 178.8k
Intangibles 152k
Other Non-Current Assets 330k
Current Liabilities 171.1k
Accounts Payable 130.2k
Other Current Liabilities 40.9k
Non-Current Liabilities 210.5k
Long-Term Debt 100k
Other Non-Current Liabilities 110.5k
Efficiency

Earnings Waterfall
Innovotech Inc

Revenue
1.2m CAD
Cost of Revenue
-385.4k CAD
Gross Profit
843.1k CAD
Operating Expenses
-1.4m CAD
Operating Income
-519.1k CAD
Other Expenses
154.6k CAD
Net Income
-364.5k CAD

Free Cash Flow Analysis
Innovotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IOT Profitability Score
Profitability Due Diligence

Innovotech Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
Low 3-Year Average ROE
33/100
Profitability
Score

Innovotech Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

IOT Solvency Score
Solvency Due Diligence

Innovotech Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
55/100
Solvency
Score

Innovotech Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IOT Price Targets Summary
Innovotech Inc

There are no price targets for IOT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IOT?

Click here to dive deeper.

Dividends

Innovotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IOT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one IOT stock?

The intrinsic value of one IOT stock under the Base Case scenario is 0.07 CAD.

Is IOT stock undervalued or overvalued?

Compared to the current market price of 0.17 CAD, Innovotech Inc is Overvalued by 60%.

Back to Top